Effect of Kinase Inhibitors on the Therapeutic Properties of Monoclonal Antibodies

mAbs - United States
doi 10.4161/19420862.2015.989020
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

The Safety of Therapeutic Monoclonal Antibodies: Implications for Cancer Therapy Including Immuno-Checkpoint Inhibitors

Physiological Research
MedicinePhysiology
2016English

597 EGFR Monoclonal Antibodies and EGFR Tyrosine Kinase Inhibitors Have Distinct Effects on the Keratinocyte Innate Immune Response

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2017English

Therapeutic Potential of Inorganic Nanoparticles for the Delivery of Monoclonal Antibodies

Journal of Nanomaterials
Materials ScienceNanotechnologyNanoscience
2015English

Pharmacological Properties of Monoclonal Antibodies Directed Against Interleukins

2015English

Integrated Flow-Through Purification for Therapeutic Monoclonal Antibodies Processing

mAbs
AllergyImmunology
2018English

Distinguishing Therapeutic Monoclonal Antibodies From Patient Monoclonal Proteins by Electrospray Time-Of-Flight Mass Spectrometry

Pathology
Forensic MedicinePathology
2020English

Impact of Depleting Therapeutic Monoclonal Antibodies on the Host Adaptive Immunity: A Bonus or a Malus?

Frontiers in Immunology
AllergyImmunology
2017English

Generation of Monoclonal Antibodies Specific to Ribosomal Protein S6 Kinase 1

Biopolymers and Cell
BiochemistryGeneticsMolecular Biology
2012English

The Pharmacology of Monoclonal Antibodies

Handbook of Experimental Pharmacology
BiochemistryToxicologyPharmaceuticsPharmacology
1994English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy